Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion type Assertion NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_head.
- NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion description "[As current strategies to treat HER2-positive breast cancer are unable to inhibit this feedback response, two great promises emerged: the combination of targeted-therapies and drugs targeting HER3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_provenance.
- NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion evidence source_evidence_literature NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_provenance.
- NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion SIO_000772 25712189 NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_provenance.
- NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion wasDerivedFrom befree-2016 NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_provenance.
- NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_assertion wasGeneratedBy ECO_0000203 NP1266038.RAPzeLbSGduNuyLMZZljG58pX5aBADtZ-vAO1CaKlWV8o130_provenance.